Axsome Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $73.9M | $88.6M | $84.7M |
| Jun 2022 | $165.4M | $180.6M | $73.4M |
| Sep 2022 | $181.6M | $339.0M | $227.5M |
| Dec 2022 | $221.9M | $331.5M | $200.8M |
| Mar 2023 | $277.4M | $389.2M | $246.5M |
| Jun 2023 | $332.8M | $611.6M | $437.1M |
| Sep 2023 | $331.3M | $600.9M | $416.6M |
| Dec 2023 | $397.3M | $588.2M | $386.2M |
| Mar 2024 | $401.7M | $545.7M | $331.4M |
| Jun 2024 | $445.4M | $548.2M | $315.7M |
| Sep 2024 | $468.6M | $561.5M | $327.3M |
| Dec 2024 | $511.5M | $568.5M | $315.4M |
| Mar 2025 | $543.5M | $596.7M | $300.9M |
| Jun 2025 | $566.7M | $639.8M | $303.0M |
| Sep 2025 | $595.5M | $669.3M | $325.3M |
| Dec 2025 | $601.5M | $689.8M | $322.9M |
| Mar 2026 | $659.0M | $713.6M | $305.1M |
| Jun 2026 | $678.1M | $761.4M | $319.9M |